iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing ... iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc. Show more
SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody immunotherapies, announced today the appointment of biotech industry veterans...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.04 | 1.63265306122 | 2.45 | 2.55 | 2.3 | 61123 | 2.41803433 | CS |
4 | -0.19 | -7.08955223881 | 2.68 | 2.97 | 2.2401 | 83005 | 2.56114227 | CS |
12 | 0.27 | 12.1621621622 | 2.22 | 3.15 | 2.0646 | 142614 | 2.63013973 | CS |
26 | 0.42 | 20.2898550725 | 2.07 | 3.15 | 1.5 | 104053 | 2.40904159 | CS |
52 | 1.07 | 75.3521126761 | 1.42 | 4.98 | 1.0214 | 1044126 | 3.32338152 | CS |
156 | -10.39 | -80.6677018634 | 12.88 | 73.2 | 1.0214 | 1421282 | 11.05338627 | CS |
260 | -2.11 | -45.8695652174 | 4.6 | 157 | 1.0214 | 6584726 | 37.37906219 | CS |
Symbole | Prix | Vol. |
---|---|---|
UVIX2x Long VIX Futures ETF | US$ 3,215 (8,25%) | 91,49M |
OPTTOcean Power Technologies Inc | US$ 0,4711 (3,97%) | 81,92M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,00 (3,27%) | 81,61M |
KULRKULR Technology Group Inc | US$ 4,66 (-2,92%) | 77,49M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,195 (10,03%) | 65,17M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales